Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.20.1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
3 Months Ended
Nov. 01, 2018
Mar. 31, 2020
Mar. 31, 2019
CRO      
Commitments and Contingencies      
Expected term 5 years    
CRO Initial clinical trials      
Commitments and Contingencies      
Expected term   2 years  
Expected cost   $ 10,000  
Cost incurred   2,534  
CRO Second clinical trials      
Commitments and Contingencies      
Expected term     3 years
Expected cost     $ 8,000
Cost incurred   1,237  
Reimbursed cost (as a percent)     50.00%
Second CRO      
Commitments and Contingencies      
Expected cost     $ 14,700
Cost incurred   $ 7,034